[Federal Register Volume 82, Number 37 (Monday, February 27, 2017)]
[Notices]
[Pages 11950-11951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03733]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The U.S. Nuclear Regulatory Commission will convene a meeting of
the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April
26-27, 2017. A sample of agenda items to be discussed during the public
session includes: (1) An update on medical-related events; (2) a
presentation by Elekta on the physical presence requirements for the
Leksell Gamma Knife[supreg] IconTM; (3) an update on
Category 3 source security and accountability evaluation initiatives;
(4) a discussion on the training and experience requirements for
authorized individuals for various modalities; (5) an update on the
patient release project; (6) a discussion on the reporting of medical
events for various modalities; (7) a discussion on patient
intervention; and (8) a discussion on medical event reporting and
impact on safety culture. The agenda is subject to change. The current
agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html or by emailing Ms. Michelle
Smethers at the contact information below.
Purpose: Discuss issues related to title 10 of the Code of Federal
Regulations (10 CFR) Part 35 Medical Use of Byproduct Material.
Date and Time for Open Sessions: April 26, 2017, from 8:00 a.m. to
2:30 p.m. and April 27, 2017, from 8:00 a.m. to 3:45 p.m.
Date and Time for Closed Sessions: April 26, 2017, from 7:30 a.m.
to 8:00 a.m.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Building, Room T2-B3, 11545 Rockville Pike,
Rockville, Maryland 20852.
PUBLIC PARTICIPATION: Any member of the public who wishes to
participate in the meeting in person or via phone should contact Ms.
Smethers using the information below. The meeting will also be webcast
live: https://video.nrc.gov/.
CONTACT INFORMATION: Michelle Smethers, email:
[email protected], telephone: (301) 415-0168.
[[Page 11951]]
Conduct of the Meeting
Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Smethers using the contact information listed
above. All submittals must be received by April 21, 2017, and must
pertain to the topic on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's Web site http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html on or about June 14, 2017.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Smethers of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in 10
CFR part 7.
Dated at Rockville, Maryland, this 21st day of February, 2017.
For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2017-03733 Filed 2-24-17; 8:45 am]
BILLING CODE 7590-01-P